Cancer Family
Thoracic Neoplasm
CI-CAN-00000054Explore in graph →
Non-malignant2,893 active trials51 approved drugs626 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000054Explore in graph →
Clinical trials
12,167 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07148648 | Institutional Experience With Chest Wall Reconstruction Using Sternal Steel Wires: A Case Series Study | completed | — | 38 | University of Health Sciences LahoreOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT04772989 | A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies(ARC-12) | completed | Phase 1 | 94 | Arcus Biosciences, Inc.INDUSTRY | 3 | Aug 28, 2025 |
| clinicaltrials |
| NCT03850912 | Symptom Management Implementation of Patient Reported Outcomes in Oncology(SIMPRO) | completed | N/A | 42,808 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT03977467 | Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor | completed | Phase 2 | 46 | SCRI Development Innovations, LLCOTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT02735746 | Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis(HFFLI) | completed | — | 60 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT02819024 | Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography | completed | N/A | 6 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT03322540 | Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) | completed | Phase 2 | 154 | Incyte CorporationINDUSTRY | 18 | Aug 22, 2025 | clinicaltrials |
| NCT03708328 | A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors | completed | Phase 1 | 134 | Hoffmann-La RocheINDUSTRY | 6 | Aug 20, 2025 | clinicaltrials |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)(GLIMMER-01) | completed | Phase 1 / Phase 2 | 69 | Palleon Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 20, 2025 | clinicaltrials |
| NCT05517083 | Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer | completed | N/A | 41 | Pusan National University HospitalOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07132593 | A Retrospective, Observational, and Descriptive Study of Pediatric Cardiac Fibroma | completed | — | 17 | China National Center for Cardiovascular DiseasesOTHER_GOV | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07132957 | A Study of AL8326 in Healthy Subjects | completed | Phase 1 | 6 | Advenchen Laboratories Nanjing Ltd.INDUSTRY | 1 | Aug 20, 2025 | clinicaltrials |
| NCT04951154 | A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer | completed | — | 33 | Janssen Research & Development, LLCINDUSTRY | 1 | Aug 19, 2025 | clinicaltrials |
| NCT01951482 | Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer | completed | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT06141005 | Feasibility of Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Lung Cancer | completed | N/A | 65 | Pusan National University HospitalOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT02327078 | A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) | completed | Phase 1 / Phase 2 | 307 | Incyte CorporationINDUSTRY | 2 | Aug 14, 2025 | clinicaltrials |
| NCT02623712 | The Watch the Spot Trial(WTS) | completed | N/A | 34,686 | Kaiser PermanenteOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT07121387 | A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer | completed | — | 221 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT02475213 | Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer | completed | Phase 1 | 146 | MacroGenicsINDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT04206072 | D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC | completed | Phase 2 / Phase 3 | 362 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05645731 | Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study | completed | — | 100 | Nicole Ezer, MD, FRCPC, MPHOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT03721120 | Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer(LIBELULE) | completed | N/A | 319 | Centre Leon BerardOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT04825834 | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)(DELFI-L101) | completed | — | 2,992 | Delfi Diagnostics Inc.INDUSTRY | 2 | Aug 8, 2025 | clinicaltrials |
| NCT07111104 | Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma(ARIS) | completed | — | 350 | Hopitaux Prives de Metz, Groupe UNEOSOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT02681549 | Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 41 | Yale UniversityOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05585034 | Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors | completed | Phase 1 | 60 | Xencor, Inc.INDUSTRY | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07065422 | AI Models for Predicting Occult Pleural Dissemination in NSCLC | completed | — | 326 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07107893 | Comparison of Double Lumen Tube Location Verification Techniques in Single Lung Ventilation | completed | — | 93 | Kayseri City HospitalOTHER_GOV | 1 | Aug 6, 2025 | clinicaltrials |
| NCT02903914 | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors | completed | Phase 1 | 260 | Incyte CorporationINDUSTRY | 4 | Aug 5, 2025 | clinicaltrials |
| NCT05253807 | Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration(FIGHT-210) | completed | Phase 2 | 8 | Incyte CorporationINDUSTRY | 5 | Aug 5, 2025 | clinicaltrials |
| NCT06048367 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor(CNSI-Fe(II)) | completed | Phase 1 | 19 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06617390 | A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments(RECAP) | completed | — | 1,041 | Daiichi SankyoINDUSTRY | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07100444 | Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival | completed | — | 139 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT00243867 | Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer | completed | Phase 3 | 518 | American Regent, Inc.INDUSTRY | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05212285 | Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer | completed | — | 469 | Fudan UniversityOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07099105 | Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer(SP vs MP robot) | completed | — | 339 | Korea University Guro HospitalOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05993273 | Pain Control After VATS Anatomical Pulmonary Resections | completed | N/A | 75 | University Hospital PadovaOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06544200 | Intra-operative Air Leak Management After Minimally Invasive Lung Segmental Resection | completed | N/A | 104 | University Hospital PadovaOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT00199615 | Follow-up of Patients With Curative-intent Surgical Resection for NSCLC | completed | N/A | 73 | University Hospital, LimogesOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT04830826 | A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China(ADDRESS) | completed | — | 1,490 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05292859 | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | completed | — | 7 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05303493 | Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma | completed | Phase 1 | 45 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT02769832 | Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | completed | Phase 2 | 32 | Muhammad FurqanOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT02392455 | VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC) | completed | — | 817 | Boehringer IngelheimINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT04051827 | Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 26 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Jul 28, 2025 | clinicaltrials |
| NCT00284778 | Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 150 | University Hospital, LimogesOTHER | 1 | Jul 24, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Aug 29, 2025source: clinicaltrials